Company
UniPharma Co. Ltd
Headquarters: Taipei, Taiwan
Employees: 42
Market Cap
TW$511.2 Million
TWD as of Jan. 1, 2024
US$16.7 Million
UniPharma Co. Ltd Categories
Taiwan Healthcare Drug Manufacturers—Specialty & GenericTaiwan Healthcare Taiwan Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
UniPharma Co., Ltd. engages in the drug development activities. The company offers adhesion reduction and anesthesia solutions; and antidotes, as well as medical devices and in vitro-diagnostic products. IT also provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. Additionally, the company develops bio-markers for the diagnosis of neurological disease; and operates a laboratory for neurological bio-markers. UniPharma Co., Ltd. was founded in 1998 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
UniPharma Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6621 wb_incandescent